MicroRNA-1作为先天性心脏病手术潜在生物标志物
本研究回顾性测量了199例连续接受先天性心脏手术的儿科患者(中位年龄1.2岁)围术期血浆miR-1,发现术后miR-1较基线中位相对升高204倍(P < .001),且与主动脉阻断时间、ICU停留时间、早期严重心血管事件、高血管活性-正性肌力评分及通气指数相关,提示miR-1可能预测术后短期结局。
要点
- 术后血浆miR-1较基线中位相对升高204倍(P < .001)。
- 术后miR-1与ICU停留时间、早期严重心血管事件正相关。
- miR-1或可辅助识别需更密集支持的体外循环缺血并发症患者。
核心结论
- 血浆miR-1是有潜力的循环生物标志物,可预测儿科心脏手术早期术后结局并指导临床管理。
研究设计与样本
- 回顾性队列研究,纳入199例连续接受先天性心脏手术的儿科患者,中位年龄1.2岁,术前及术毕采血,用逆转录定量PCR测量血浆miR-1。
主要发现
- 基线血浆miR-1在不同诊断间无差异,术中升高(中位相对升高204倍,P < .001),术后与主动脉阻断时间相关(P < .001)。
- 术毕miR-1与ICU停留时间(P < .001)、早期严重心血管事件(P = .01)、高血管活性-正性肌力评分(P = .001)及通气指数(P < .001)正相关。
关键数值与推荐
- miR-1以拷贝/μL及相对于外源性cel-miR-39的相对表达量表示。
- 术中miR-1中位相对升高204倍(P < .001)。
- 术毕miR-1与ICU停留时间P < .001、早期严重心血管事件P = .01、高血管活性-正性肌力评分P = .001、通气指数P < .001相关。
临床怎么用
- 围术期循环miR-1测量或可辅助预测儿科先天性心脏手术术后短期结局,帮助早期识别需更密集支持的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pediatric congenital heart surgery (CHS) involves intracardiac, valvular, and vascular repairs. Accurate tools to aid short-term outcome prediction in pediatric CHS are lacking. Clinical scores, such as the vasoactive-inotrope score and ventilation index, are used to define outcome in clinical studies. MicroRNA-1-3p (miR-1) is expressed by both cardiomyocytes and vascular cells and is regulated by hypoxia. In adult patients, miR-1 increases in the circulation after open-heart cardiac surgery, suggesting its potential as a clinical biomarker. Thus, we investigated whether perioperative circulating miR-1 measurements can help predict post-CHS short-term outcomes in pediatric patients. METHODS: Plasma miR-1 was retrospectively measured in a cohort of 199 consecutive pediatric CHS patients (median age 1.2 years). Samples were taken before surgery and at the end of the operation. Plasma miR-1 concentration was measured by reverse transcription-quantitative polymerase chain reaction and expressed as miR-1 copies/μL and as relative expression to spiked-in exogenous cel-miR-39. RESULTS: Baseline plasma miR-1 did not vary across different diagnoses, increased during surgery (204-fold median relative increase, P < .001), and was associated with aortic crossclamp duration postoperatively (P < .001). Importantly, miR-1 levels at the end of the operation positively correlated with intensive care stay (P < .001), early severe cardiovascular events (P = .01), and with high vasoactive-inotrope score (P = .001) and ventilation index (P < .001), suggesting that miR-1 could accelerate the identification of patients with cardiopulmonary bypass-related ischemic complications, requiring more intensive support. CONCLUSIONS: Our study suggests miR-1 as a novel potential circulating biomarker to predict early postoperative outcome and inform clinical management in pediatric heart surgery.
引用
- Stoica SC, Dorobantu DM, Vardeu A, et al. MicroRNAs as potential biomarkers in congenital heart surgery. J Thorac Cardiovasc Surg. 2019. PMID: 31043318. doi:10.1016/j.jtcvs.2019.03.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。